ArticleFrontiers in oncology2021

Exploration of a Novel Prognostic Risk Signature and Its Effect on the Immune Response in Nasopharyngeal Carcinoma.

Shuang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.